News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>Jefferies Cuts ALI HEALTH (00241.HK) TP to HKD5.3, Reiterates Buy
ALI HEALTH (00241.HK) launched the "Hydrion" app, positioning it as an early AI pioneer targeting doctors, in collaboration with The BMJ to provide evidence-based clinica...
Reset
Send
The window will close in 5 seconds
<Research>Jefferies Cuts ALI HEALTH (00241.HK) TP to HKD5.3, Reiterates Buy
Close
Recommend
21
Positive
26
Negative
14
 
 

ALI HEALTH (00241.HK)  0.000 (0.000%)    Short selling $153.16M; Ratio 34.469%   launched the "Hydrion" app, positioning it as an early AI pioneer targeting doctors, in collaboration with The BMJ to provide evidence-based clinical decision support, Jefferies said in its report. Initial product testing shows strong usability, a low hallucination rate and robust clinical reasoning.

Management expects to invest RMB200-300 million annually in AI R&D during FY2027-29, targeting 2 million MAUs within three years and aiming for "Hydrion" to achieve breakeven in 2029.

Related NewsALI HEALTH (00241.HK) and JD HEALTH (06618.HK) Drop 3%-5% as CLSA Says Impact from GLP-1 Online Sales Restrictions Limited; Nomura: Market Overreacted
As a leading B2C participant, ALI HEALTH's internet hospital workflow has been officially authorized and is largely unaffected by recent news regarding tightened GLP-1 prescription restrictions in Jiangxi and Shanghai.

The broker lowered its TP on ALI HEALTH from HKD6 to HKD5.3 to reflect uncertainties such as commercialization pace, but maintained its Buy rating.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-22 16:25.)

Auto-translated by AI
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.